BDBM50100380 5-Oxo-hexanoic acid (1-{[(S)-1-carbamoyl-2-(3,4-dichloro-phenyl)-ethylcarbamoyl]-methyl}-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[b]azepin-3-yl)-amide::5-Oxo-hexanoic acid (1-{[(S)-1-carbamoyl-2-(3,4-dichloro-phenyl)-ethylcarbamoyl]-methyl}-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide::CHEMBL284120
SMILES: CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O
InChI Key: InChIKey=BADTYUHLCFJVTK-ZGAORZAOSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxytocin receptor (Homo sapiens (Human)) | BDBM50100380![]() (5-Oxo-hexanoic acid (1-{[(S)-1-carbamoyl-2-(3,4-di...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Inhibition of binding of [3H]oxytocin with human oxytocin receptor | Bioorg Med Chem Lett 11: 1301-5 (2001) BindingDB Entry DOI: 10.7270/Q27H1MS3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Oxytocin receptor (Homo sapiens (Human)) | BDBM50100380![]() (5-Oxo-hexanoic acid (1-{[(S)-1-carbamoyl-2-(3,4-di...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Medicines Research Centre Curated by ChEMBL | Assay Description Inhibitory concentration required for antagonist activity against oxytocin receptor | Bioorg Med Chem Lett 11: 1297-300 (2001) BindingDB Entry DOI: 10.7270/Q2T72GQF | |||||||||||
More data for this Ligand-Target Pair |